BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jilesen AP, van Eijck CH, Busch OR, van Gulik TM, Gouma DJ, van Dijkum EJ. Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor. World J Surg. 2016;40:715-728. [PMID: 26608956 DOI: 10.1007/s00268-015-3341-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Giuliani T, De Pastena M, Paiella S, Marchegiani G, Landoni L, Festini M, Ramera M, Marinelli V, Casetti L, Esposito A, Bassi C, Salvia R. Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity Score-Matched Analysis. Ann Surg 2023;277:e609-16. [PMID: 33856383 DOI: 10.1097/SLA.0000000000004911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
2 Meng Y, Fan Z, Yang J, Li Y, Zhan H. Comment on “Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort”. Annals of Surgery Open 2023;4:e266. [DOI: 10.1097/as9.0000000000000266] [Reference Citation Analysis]
3 Roesel R, Bernardi L, Bonino MA, Popeskou SG, Garofalo F, Cristaudi A. Minimally-invasive versus open pancreatic enucleation: systematic review and metanalysis of short-term outcomes. HPB (Oxford) 2023:S1365-182X(23)00053-9. [PMID: 36958987 DOI: 10.1016/j.hpb.2023.02.014] [Reference Citation Analysis]
4 Shimura M, Kato H, Asano Y, Ito M, Arakawa S, Koike D, Ochi T, Yasuoka H, Kawai T, Higashiguchi T, Tani H, Kunimura Y, Kondo Y, Nagata H, Sato H, Kamio K, Horiguchi A. Clinical feasibility of duodenum-preserving pancreatic head resection for neuroendocrine tumors of the pancreatic head as intermediate procedure between enucleation and pancreaticoduodenectomy.. [DOI: 10.21203/rs.3.rs-2465903/v1] [Reference Citation Analysis]
5 Molasy B, Zemła P, Mrowiec S, Kusnierz K. Utility of fistula risk score in assessing the risk of postoperative pancreatic fistula occurrence and other significant complications after different types of pancreatic neuroendocrine tumor resections. Ann Surg Treat Res 2022;103:340-9. [PMID: 36601342 DOI: 10.4174/astr.2022.103.6.340] [Reference Citation Analysis]
6 Lysanyuk MV, Romashchenko PN, Maistrenko NA. Modern opportunities and problematic aspects of diagnostics and treatment of patients with neuroendocrine tumors. Perm Medical Journal 2022;39:58-68. [DOI: 10.17816/pmj39558-68] [Reference Citation Analysis]
7 Yu X, Wang W, Yu S, Yang C, Huang X, Yuan Z. The role of main pancreatic duct stent in the local excision of pancreatic head benign tumors -- A Cohort Study.. [DOI: 10.21203/rs.3.rs-2031226/v1] [Reference Citation Analysis]
8 van Beek DJ, Takkenkamp TJ, Wong-Lun-Hing EM, de Kleine RHJ, Walenkamp AME, Klaase JM, Nijkamp MW, Valk GD, Molenaar IQ, Hagendoorn J, van Santvoort HC, Borel Rinkes IHM, Hoogwater FJH, Vriens MR. Risk factors for complications after surgery for pancreatic neuroendocrine tumors. Surgery 2022;172:127-36. [PMID: 35341591 DOI: 10.1016/j.surg.2022.02.007] [Reference Citation Analysis]
9 Kaiser J, Alhalabi KT, Hinz U, Mayer P, Tjaden C, Büchler MW, Hackert T, Loos M. Enucleation for low-grade branch duct intraductal papillary mucinous neoplasms: Long-term follow-up. Surgery 2022:S0039-6060(22)00300-2. [PMID: 35680446 DOI: 10.1016/j.surg.2022.04.035] [Reference Citation Analysis]
10 Nießen A, Bechtiger FA, Hinz U, Lewosinska M, Billmann F, Hackert T, Büchler MW, Schimmack S. Enucleation Is a Feasible Procedure for Well-Differentiated pNEN-A Matched Pair Analysis. Cancers (Basel) 2022;14. [PMID: 35626174 DOI: 10.3390/cancers14102570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sutton TL, Pommier RF, Mayo SC, Gilbert EW, Papavasiliou P, Babicky M, Gerry J, Sheppard BC, Worth PJ. Similar Outcomes in Minimally Invasive versus Open Management of Primary Pancreatic Neuroendocrine Tumors: A Regional, Multi-Institutional Collaborative Analysis. Cancers (Basel) 2022;14. [PMID: 35326539 DOI: 10.3390/cancers14061387] [Reference Citation Analysis]
12 Minczeles NS, van Eijck CHJ, van Gils MJ, van Velthuysen MF, Nieveen van Dijkum EJM, Feelders RA, de Herder WW, Brabander T, Hofland J. Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients. Eur J Nucl Med Mol Imaging 2022. [PMID: 35230492 DOI: 10.1007/s00259-022-05734-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shen X, Yang X. Comparison of Outcomes of Enucleation vs. Standard Surgical Resection for Pancreatic Neoplasms: A Systematic Review and Meta-Analysis. Front Surg 2022;8:744316. [DOI: 10.3389/fsurg.2021.744316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Havasi A, Sur D, Cainap SS, Lungulescu CV, Gavrilas LI, Cainap C, Vlad C, Balacescu O. Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers. Int J Mol Sci 2022;23. [PMID: 35163032 DOI: 10.3390/ijms23031109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Shah MM, Datta J, Merchant NB, Kooby DA. Landmark Series: Importance of Pancreatic Resection Margins. Ann Surg Oncol 2022;29:1542-50. [PMID: 34985731 DOI: 10.1245/s10434-021-11168-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 de Ponthaud C, Menegaux F, Gaujoux S. Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know. Cancers (Basel) 2021;13:5969. [PMID: 34885079 DOI: 10.3390/cancers13235969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Frey S, Mirallié E, Le Bras M, Regenet N. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel) 2021;13:5954. [PMID: 34885063 DOI: 10.3390/cancers13235954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Naples R, Thomas JD, Orabi DA, Reynolds JP, Robertson S, Siperstein AE, Walsh RM, Simon R, Shin JJ, Jin J, Krishnamurthy VD, Berber E. A critical analysis of laparoscopic and open approaches to sporadic pancreatic insulinoma resection in the modern era. Am J Surg 2021:S0002-9610(21)00601-2. [PMID: 34702489 DOI: 10.1016/j.amjsurg.2021.10.011] [Reference Citation Analysis]
19 Altimari M, Abad J, Chawla A. The role of oncologic resection and enucleation for small pancreatic neuroendocrine tumors. HPB (Oxford) 2021;23:1533-40. [PMID: 33832835 DOI: 10.1016/j.hpb.2021.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Vaghaiwalla T, Keutgen XM. Surgical Management of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am 2020;29:243-52. [PMID: 32151358 DOI: 10.1016/j.soc.2019.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
21 Beane JD, Borrebach JD, Billderback A, Onuma AE, Adam MA, Zureikat AH, Pitt HA. Small pancreatic neuroendocrine tumors: Resect or enucleate? The American Journal of Surgery 2021;222:29-34. [DOI: 10.1016/j.amjsurg.2020.12.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
22 Melita G, Pallio S, Tortora A, Crinò SF, Macrì A, Dionigi G. Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms. J Clin Med 2021;10:2638. [PMID: 34203922 DOI: 10.3390/jcm10122638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Heidsma CM, Tsilimigras DI, van Dieren S, Rocha F, Abbott DE, Fields R, Smith PM, Poultsides GA, Cho C, Dillhoff M, Lopez-Aguiar AG, Kanji Z, Fisher A, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, Nieveen van Dijkum EJM, Maithel SK, Pawlik TM. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors. HPB (Oxford) 2021;23:413-21. [PMID: 32771338 DOI: 10.1016/j.hpb.2020.06.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
24 Nieveen van Dijkum EJM, Engelsman AF. Diagnosis and Management of Functional Pancreatic Neuroendocrine Tumors. Endocrine Surgery Comprehensive Board Exam Guide 2021. [DOI: 10.1007/978-3-030-84737-1_27] [Reference Citation Analysis]
25 Partelli S, Ramage JK, Massironi S, Zerbi A, Kim HB, Niccoli P, Panzuto F, Landoni L, Tomazic A, Ibrahim T, Kaltsas G, Bertani E, Sauvanet A, Segelov E, Caplin M, Coppa J, Armstrong T, Weickert MO, Butturini G, Staettner S, Boesch F, Cives M, Moulton CA, He J, Selberherr A, Twito O, Castaldi A, De Angelis CG, Gaujoux S, Almeamar H, Frilling A, Vigia E, Wilson C, Muffatti F, Srirajaskanthan R, Invernizzi P, Lania A, Kwon W, Ewald J, Rinzivillo M, Nessi C, Smid LM, Gardini A, Tsoli M, Picardi EE, Hentic O, Croagh D, Toumpanakis C, Citterio D, Ramsey E, Mosterman B, Regi P, Gasteiger S, Rossi RE, Smiroldo V, Jang JY, Falconi M. Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study. Front Med (Lausanne) 2020;7:598438. [PMID: 33425946 DOI: 10.3389/fmed.2020.598438] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
26 Rimbaş M, Horumbă M, Rizzatti G, Crinò SF, Gasbarrini A, Costamagna G, Larghi A. Interventional endoscopic ultrasound for pancreatic neuroendocrine neoplasms. Dig Endosc 2020;32:1031-41. [PMID: 31995848 DOI: 10.1111/den.13635] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
27 Heidsma CM, Tsilimigras DI, Rocha F, Abbott DE, Fields R, Smith PM, Poultsides GA, Cho C, van Eijck C, van Dijkum EN, Maithel SK, Pawlik TM; US Neuroendocrine Tumor Study Group. Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2 cm. J Surg Oncol 2020;122:1393-400. [PMID: 32783272 DOI: 10.1002/jso.26158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
28 Horton TM, Sundaram V, Lee CH, Hornbacker K, Van Vleck A, Benjamin KN, Zemek A, Longacre TA, Kunz PL, Annes JP. PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker. Sci Rep 2020;10:10943. [PMID: 32616904 DOI: 10.1038/s41598-020-68071-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, Hou BH. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World J Gastroenterol 2020; 26(19): 2305-2322 [PMID: 32476795 DOI: 10.3748/wjg.v26.i19.2305] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 50] [Article Influence: 16.7] [Reference Citation Analysis]
30 Albers MB, Almquist M, Bergenfelz A, Nordenström E. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias. Langenbecks Arch Surg 2020;405:137-43. [PMID: 32291468 DOI: 10.1007/s00423-020-01869-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
31 Regmi P, Yang Q, Hu HJ, Liu F, Karn HR, Ma WJ, Ran CD, Li FY. Overall Postoperative Morbidity and Pancreatic Fistula Are Relatively Higher after Central Pancreatectomy than Distal Pancreatic Resection: A Systematic Review and Meta-Analysis. Biomed Res Int 2020;2020:7038907. [PMID: 32219139 DOI: 10.1155/2020/7038907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Chin KM, Goh BKP. Robotic enucleation of a pancreatic uncinate neuroendocrine tumor - a unique parenchyma-saving strategy for uncinate tumors. Ann Hepatobiliary Pancreat Surg 2020;24:97-103. [PMID: 32181437 DOI: 10.14701/ahbps.2020.24.1.97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Heidsma CM, Hyer M, Tsilimigras DI, Rocha F, Abbott DE, Fields R, Smith PM, Poultsides GA, Cho C, Maithel SK, Pawlik TM; Other Members of the US Neuroendocrine Tumor Study Group. Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group. J Surg Oncol. 2020;121:1201-1208. [PMID: 32185804 DOI: 10.1002/jso.25900] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
34 Laird AM, Libutti SK. Advances in the Diagnosis and Management of Nonfunctional Pancreatic Neuroendocrine Tumors. Advances in Treatment and Management in Surgical Endocrinology 2020. [DOI: 10.1016/b978-0-323-66195-9.00020-0] [Reference Citation Analysis]
35 Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, Minter RM, Lairmore TC, Tseng JF, Zeh HJ, Libutti SK, Singh G, Lee JE, Hope TA, Kim MK, Menda Y, Halfdanarson TR, Chan JA, Pommier RF. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors. Pancreas 2020;49:1-33. [PMID: 31856076 DOI: 10.1097/MPA.0000000000001454] [Cited by in Crossref: 142] [Cited by in F6Publishing: 130] [Article Influence: 47.3] [Reference Citation Analysis]
36 Darbà J, Marsà A. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources. BMC Cancer 2019;19:1226. [PMID: 31842791 DOI: 10.1186/s12885-019-6412-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
37 Romashchenko PN, Maistrenko NA, Lysyuk VM. ANALYSIS OF OUTCOMES SURGICAL TREATMENT OF PATIENTS WITH NEUROENDOCRINE TUMORS. Bulletin of the Russian Military Medical Academy 2019;21:109-113. [DOI: 10.17816/brmma13060] [Reference Citation Analysis]
38 Gharios J, Hain E, Dohan A, Prat F, Terris B, Bertherat J, Coriat R, Dousset B, Gaujoux S. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas. Best Pract Res Clin Endocrinol Metab 2019;33:101294. [PMID: 31351817 DOI: 10.1016/j.beem.2019.101294] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Dalla Valle R, Cremaschi E, Lamecchi L, Guerini F, Rosso E, Iaria M. Open and minimally invasive pancreatic neoplasms enucleation: a systematic review. Surg Endosc 2019;33:3192-9. [PMID: 31363894 DOI: 10.1007/s00464-019-06967-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
40 Mintziras I, Keck T, Werner J, Fichtner-Feigl S, Wittel U, Senninger N, Vowinkel T, Köninger J, Anthuber M, Geißler B, Bartsch DK; StuDoQ|Pancreas Study Group of the German Society for General, Visceral Surgery (DGAV). Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ|Pancreas registry. Surg Today 2019;49:1013-21. [PMID: 31240463 DOI: 10.1007/s00595-019-01838-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Scott AT, Howe JR. Evaluation and Management of Neuroendocrine Tumors of the Pancreas. Surg Clin North Am 2019;99:793-814. [PMID: 31255207 DOI: 10.1016/j.suc.2019.04.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 9.5] [Reference Citation Analysis]
42 Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Covey AM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Gerdes H, Allen PJ, Schattner MA. Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. HPB (Oxford) 2019;21:434-43. [PMID: 30293867 DOI: 10.1016/j.hpb.2018.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
43 Nell S, Borel Rinkes IHM, Verkooijen HM, Bonsing BA, van Eijck CH, van Goor H, de Kleine RHJ, Kazemier G, Nieveen van Dijkum EJ, Dejong CHC, Valk GD, Vriens MR; DMSG. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors. Ann Surg 2018;267:352-6. [PMID: 27811505 DOI: 10.1097/SLA.0000000000002050] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
44 Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R. II- Les tumeurs neuroendocrines pancréatiques sporadiques : quelle chirurgie pour la tumeur primitive ? Journal de Chirurgie Viscérale 2018;155:497-507. [DOI: 10.1016/j.jchirv.2018.05.007] [Reference Citation Analysis]
45 Ausania F, Senra Del Rio P. Lymphadenectomy in pancreatic neuroendocrine neoplasms: Why are we still debating? Pancreatology 2018;18:855-61. [PMID: 30253923 DOI: 10.1016/j.pan.2018.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
46 Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R. Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor. J Visc Surg 2018;155:483-92. [PMID: 30448206 DOI: 10.1016/j.jviscsurg.2018.08.010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Bartolini I, Bencini L, Bernini M, Farsi M, Calistri M, Annecchiarico M, Moraldi L, Coratti A. Robotic enucleations of pancreatic benign or low-grade malignant tumors: preliminary results and comparison with robotic demolitive resections. Surg Endosc 2019;33:2834-42. [PMID: 30421079 DOI: 10.1007/s00464-018-6576-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
48 Duconseil P, Marchese U, Ewald J, Giovannini M, Mokart D, Delpero JR, Turrini O. A pancreatic zone at higher risk of fistula after enucleation. World J Surg Oncol 2018;16:177. [PMID: 30157952 DOI: 10.1186/s12957-018-1476-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Chou A, Itchins M, de Reuver PR, Arena J, Clarkson A, Sheen A, Sioson L, Cheung V, Perren A, Nahm C, Mittal A, Samra JS, Pajic M, Gill AJ. ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors. Hum Pathol 2018;82:249-57. [PMID: 30081149 DOI: 10.1016/j.humpath.2018.07.032] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
50 Di Benedetto F, Magistri P, Ballarin R, Tarantino G, Bartolini I, Bencini L, Moraldi L, Annecchiarico M, Guerra F, Coratti A. Ultrasound-Guided Robotic Enucleation of Pancreatic Neuroendocrine Tumors. Surg Innov 2019;26:37-45. [PMID: 30066609 DOI: 10.1177/1553350618790711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
51 Bartolini I, Bencini L, Risaliti M, Ringressi MN, Moraldi L, Taddei A. Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation. Gastroenterol Res Pract 2018;2018:9647247. [PMID: 30140282 DOI: 10.1155/2018/9647247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
52 Guerra F, Giuliani G, Bencini L, Bianchi PP, Coratti A. Minimally invasive versus open pancreatic enucleation. Systematic review and meta-analysis of surgical outcomes. J Surg Oncol 2018;117:1509-16. [DOI: 10.1002/jso.25026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
53 Mackay TM, Genç CG, Takkenberg RB, Besselink MG, Somers I, Nieveen van Dijkum EJM. New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors. J Surg Oncol 2018;117:1548-55. [PMID: 29572825 DOI: 10.1002/jso.25051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
54 Shirota T, Nagakawa Y, Sahara Y, Takishita C, Hijikata Y, Hosokawa Y, Nakajima T, Osakabe H, Katsumata K, Tsuchida A. Surgical resection of neuroendocrine tumors of the pancreas (pNETs) by minimally invasive surgery: the laparoscopic approach. Gland Surg 2018;7:12-9. [PMID: 29629315 DOI: 10.21037/gs.2017.11.06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
55 Chew C, Bonney GK. Pancreatic Neuroendocrine Tumours. Evidence-Based Endocrine Surgery 2018. [DOI: 10.1007/978-981-10-1124-5_36] [Reference Citation Analysis]
56 Cabús SS, Fernández-cruz L. Minimally Invasive Enucleation of Pancreatic Tumors. Minimally Invasive Surgery of the Pancreas 2018. [DOI: 10.1007/978-88-470-3958-2_16] [Reference Citation Analysis]
57 Tamburrino D, Partelli S, Falconi M. Pancreatic Neuroendocrine Tumours. Surgical Diseases of the Pancreas and Biliary Tree 2018. [DOI: 10.1007/978-981-10-8755-4_13] [Reference Citation Analysis]
58 Masui T, Sato A, Nakano K, Uchida Y, Yogo A, Anazawa T, Nagai K, Kawaguchi Y, Takaori K, Uemoto S. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis. Ann Surg Oncol 2018;25:528-34. [PMID: 29164413 DOI: 10.1245/s10434-017-6260-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
59 Sallinen V, Le Large TY, Galeev S, Kovalenko Z, Tieftrunk E, Araujo R, Ceyhan GO, Gaujoux S. Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis. HPB (Oxford) 2017;19:310-20. [PMID: 28254159 DOI: 10.1016/j.hpb.2016.12.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 12.5] [Reference Citation Analysis]
60 Edwin B, Sahakyan MA, Abu Hilal M, Besselink MG, Braga M, Fabre JM, Fernández-Cruz L, Gayet B, Kim SC, Khatkov IE; EAES Consensus Conference Study Group. Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference. Surg Endosc 2017;31:2023-41. [PMID: 28205034 DOI: 10.1007/s00464-017-5414-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 10.2] [Reference Citation Analysis]
61 Liu JB, Baker MS. Surgical Management of Pancreatic Neuroendocrine Tumors. Surg Clin North Am. 2016;96:1447-1468. [PMID: 27865287 DOI: 10.1016/j.suc.2016.07.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
62 Sahakyan MA, Røsok BI, Kazaryan AM, Barkhatov L, Haugvik SP, Fretland ÅA, Ignjatovic D, Labori KJ, Edwin B. Role of laparoscopic enucleation in the treatment of pancreatic lesions: case series and case-matched analysis. Surg Endosc 2017;31:2310-6. [PMID: 27620912 DOI: 10.1007/s00464-016-5233-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
63 Zhou Y, Zhao M, Wu L, Ye F, Si X. Short- and long-term outcomes after enucleation of pancreatic tumors: An evidence-based assessment. Pancreatology 2016;16:1092-8. [PMID: 27423534 DOI: 10.1016/j.pan.2016.07.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]